The number of people with susceptibility test result for rifampicin in Switzerland
Switzerland: The number of people with susceptibility test result for rifampicin was 87.3 in 2021. ▬ Flat
Latest (2021)
87.3
Change on year
down 3.5%
World rank
79th
of 146 countries
All-time high
95.54
in 2019
All-time low
87.3
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Switzerland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Switzerland recorded 87.3 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 3.5% on the previous year and down 3.9% over five years.
Switzerland ranks 79th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 90.82 | — |
| 2018 | 92.55 | +1.9% |
| 2019 | 95.54 | +3.2% |
| 2020 | 90.48 | -5.3% |
| 2021 | 87.3 | -3.5% |
Switzerland compared with similar countries
- Switzerland's 87.3 is below the median for high income countries, which is 92.6, 94% of the median. (56 countries reporting)
- Switzerland's 87.3 is below the median for Europe & Central Asia, which is 93.52, 93% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 92.97 | 90.82 | 95.54 | 3 |
| 2020s | 88.89 | 87.3 | 90.48 | 2 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,104 deaths per 1,000 people (2090)
- Number of infants who die before age 1 46 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2023)
- Population ages 00-04, female, annual growth rate 0.0481 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0233 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0927 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Switzerland?
- The number of people with susceptibility test result for rifampicin in Switzerland was 87.3 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Switzerland?
- The highest recorded value was 95.54 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Switzerland?
- The lowest recorded value was 87.3 in 2021.
- How does Switzerland rank for the number of people with susceptibility test result for rifampicin?
- Switzerland ranks 79th out of 146 countries with data for 2021.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).